Profiel
Marco Liguori is currently the General Manager at Orphan Europe SARL.
Previously, he worked as the VP, Director-Special Care & Orphan Drug at Recordati SpA in 2011.
He holds an MBA from INSEAD.
Actieve functies van Marco Liguori
| Bedrijven | Functie | Begin |
|---|---|---|
Orphan Europe SARL
 Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | President | - |
Eerdere bekende functies van Marco Liguori
| Bedrijven | Functie | Einde |
|---|---|---|
| RECORDATI | Corporate Officer/Principal | - |
Opleiding van Marco Liguori
| INSEAD | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RECORDATI | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Health Technology |